Basis for hormonal management of advanced prostate cancer
โ Scribed by Jack Geller
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 626 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
One of the most intriguing features of prostate cancer epidemiology is the marked international and racial-ethnic variation in risk. There is a 30-50-fold difference in risk between African American men, at the highest end of this racial-ethnic spectrum of risk, and native Japanese and Chinese men,
Twenty patients with advanced prostate cancer have been treated with an intermittent endocrine therapy schedule. Hormone therapy (diethylstilbestrol in 19 patients and flutamide in 1 patient) was administered until a clinical response was clearly demonstrated and then it was withheld until symptoms
## Background: Given the variable natural history of prostate cancer, prognostic parameters are needed to help guide treatment decisions in individual patients. in some series, analysis of dna ploidy has correlated well with prognosis. this review was performed to determine whether flow cytometry c